These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 16202787

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ, Hoffman G, Laessig RH, Kopish GJ, Litsheim TJ, Farrell PM.
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB, Comeau AM.
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [Abstract] [Full Text] [Related]

  • 4. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
    Farrell PM, Koscik RE.
    Pediatrics; 1996 Apr; 97(4):524-8. PubMed ID: 8632940
    [Abstract] [Full Text] [Related]

  • 5. [French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening].
    Sermet-Gaudelus I, Munck A, Rota M, Roussey M, Feldmann D, Nguyen-Khoa T, Groupe de travail "Dépistage néonatal" de la Fédération des centres de ressources et de compétences de la mucoviscidose.
    Arch Pediatr; 2010 Sep; 17(9):1349-58. PubMed ID: 20719482
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
    Tluczek A, Koscik RL, Farrell PM, Rock MJ.
    Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
    [Abstract] [Full Text] [Related]

  • 10. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, Castellani C, ECFS CF Neonatal Screening Working Group.
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comparison of the classical Gibson-Cooke methods and the chloride-sensitive electrode in sweat testing for diagnosis of cystic fibrosis].
    Riedler J, Arrer E.
    Padiatr Padol; 1991 Jan; 26(4):173-5. PubMed ID: 1749624
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis.
    Laguna TA, Lin N, Wang Q, Holme B, McNamara J, Regelmann WE.
    Pediatr Pulmonol; 2012 Aug; 47(8):736-42. PubMed ID: 22786625
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
    Soultan ZN, Foster MM, Newman NB, Anbar RD.
    J Pediatr; 2008 Dec; 153(6):857-9. PubMed ID: 19014821
    [Abstract] [Full Text] [Related]

  • 19. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D, Zybert K, Mierzejewska E, Ołtarzewski M.
    Dev Period Med; 2015 Dec; 19(1):16-24. PubMed ID: 26003066
    [Abstract] [Full Text] [Related]

  • 20. Screening for cystic fibrosis: the importance of using the correct tools.
    Shah U, Moatter T.
    J Ayub Med Coll Abbottabad; 2006 Dec; 18(1):7-10. PubMed ID: 16773960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.